InVivo Therapeutics (NSDQ:NVIV) is continuing to add sites to the Inspire study of its NeuroSpinal Scaffold, announcing today that it added a new site at the Charlottesville’s University of Virginia Health System. The Cambridge, Mass.-based company’s neuro-spinal scaffold is surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. “Spinal […]
Spine
Xtant Medical wins FDA nod for spinal laminoplasty system
Xtant Medical said today its X-Spine Systems subsidiary won FDA 510(k) clearance for its Xspan laminoplasty fixation system designed for use in the lower cervical and upper thoracic spine. Spinal laminoplasty is a surgical procedure designed to remove pressure from the spinal cord through the restructuring of the lamina through a window or opening to allow […]
InVivo raises $32m, enrolls 7th patient in Inspire study
InVivo Therapeutics (NSDQ:NVIV) said today that it cleared $32.2 million from a stock offering after an over-allotment added another 560,000 shares, and said yesterday it enrolled a 7th patient in its Inspire study. Cambridge, Mass.-based InVivo floated 3.7 million units at $7.50 per unit in the initial offering, which closed March 18, bringing in $28 million. Each unit consists […]
Judge: Doc can’t drag Globus into patent spat with Medtronic
A doctor suing Medtronic (NYSE:MDT) for allegedly infringing his patents covering spinal deformity repair devices can’t drag Globus Medical (NYSE:GMED) into the dispute, a federal judge in Pennsylvania ruled last week. Dr. Mark Barry sued Medtronic in February 2014 in a Texas federal court, alleging infringement of a trio of patents covering a “System and method for aligning vertebrae in […]
NuVasive nets $634m from convertible notes offering
NuVasive Inc. (NSDQ:NUVA) yesterday said it pulled down $634 million from a convertible debt offering it plans to use to buy back other notes coming due next year. San Diego-based NuVasive said the haul included a $100 million over-allotment for the 2.25% notes due in 2021. The spinal implant maker said it plans to spend about $66 million of […]
InVivo prices $28m offering, shares slide
InVivo Therapeutics (NSDQ:NVIV) shares plunged today after the company priced a $28 million offering it plans to use to fund the Inspire clinical trial of its neuro-spinal scaffold. Each unit of the $7.50-per-share offering consists of a share of common stock and half of a 5-year warrant with an exercise price of $10, Cambridge, Mass.-based InVivo said. […]
Life Spine wins FDA 510(k) for Prolift interbody fusion system
Life Spine said Tuesday it won FDA 510(k) for its Prolift expandable interbody fusion system. The Hunley, Ill.-based company’s Prolift system is all titanium and designed to restore disk height, in-situ, for minimally invasive posterior lumbar interbody fusion procedures, transforaminal lumbar interbody fusion procedures and oblique approaches, the company said. “The Prolift Expandable Interbody System […]
Wenzel Spine launches VariLift LX interbody fusion device
Spinal fusion device developer Wenzel Spine said today it launched the VariLift-LX system next-generation interbody stand-alone fusion device, and that the 1st implantation with the device was recently performed. The newly released device is available in 2 lengths and 5 heights, and is fully expandable without having to disengage instrumentation during implantation, and also allows […]
Japan OKs NuVasive’s Reline spine fixation system
NuVasive Inc. (NSDQ:NUVA) said today that it’s planning a launch later this year for its Reline posterior fixation system in Japan, after winning Shonin approval there. The approval is the final hurdle to launching NuVasive’s Integrated Global Alignment platform in Japan, the company said. “Japan’s exceptional growth over the last 3 years demonstrates the clear benefit of […]
Nanovis wins NIH grant for FortiCore
Regenerative life sciences company Nanovis said today it won a grant from the National Institute of Health’s National Institute on Aging to fund pre-clinical studies of its FortiCore interbody fusion device. Carmel, Ind.-based Nanovis said the grant is the 8th that the company has received from the NIH and other research organizations. “The surface structure […]
InVivo continues Inspire study expansion, adds Thomas Jefferson Univ. Hospital
InVivo Therapeutics (NSDQ:NVIV) shows no signs of stopping the momentum in its Inspire trial, announcing today that it added Philadelphia’s Thomas Jefferson University Hospital as a clinical site for the Inspire study of its neuro-spinal scaffold, designed to treat patients with complete thoracic AIS A spinal cord injuries. The Cambridge, Mass.-based company’s neuro-spinal scaffold is surgically […]